.avif)
Onyx is building a “virtual immune system” to enable faster and safer development of precision medicines for autoimmune diseases. The company runs IRB-approved research studies that deeply profile conditions such as rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, and psoriasis by integrating multiomics data with longitudinal patient records. Founded by UC Berkeley PhDs Roger Chen and Amit Lakhani, Onyx operates a research lab in Berkeley, California, with a privacy-first approach to participant data.
.svg)
